Viroclinics-DDL, today announced the launch of Viroclinics Xellerate, a newly formed Business Unit focused on clinical trial support and global logistics services.
Rotterdam, the Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a renewal for collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects.
ENPICOM and Viroclinics-DDL receive joint MIT R&D ZH subsidy subsidy to accelerate and improve antibody and vaccine discovery and development
Partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics.
CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
The Coalition for Epidemic Preparedness Innovations (CEPI) has today announced partnerships with five clinical sample testing laboratories to create a centralised global network to reliably assess and compare the immunological responses generated by COVID-19 vaccine candidates.
The two companies bring their existing partnership to the next level by developing customized services to assist pharma, biotech and governmental clients with clinical diagnostics and global logistical services.
Subscribe to our newsletter for the latest insights on early stage, (pre)clinical research, cold chain logistics and assay development services.